Last reviewed · How we verify

NCT06059365: ASI2

Clinical Trial for a Outpatient Clinical Management for Complicated Acute Appendicitis

Status unknown NA Last updated 28 September 2023
What this trial tests

NA trial testing Hospitalization in Acute Appendicitis in 92 participants. Status unknown.

Timeline
1 November 2023
Primary endpoint
1 November 2023
1 November 2023

Quick facts

Lead sponsorHJ23
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment92
Start date1 November 2023
Primary completion1 November 2023
Estimated completion1 November 2023

Drugs / interventions tested

Conditions studied

Sponsor

HJ23 — full company profile →

Who can join

Adults 18 to 80, any sex, with Acute Appendicitis or Appendicitis Perforated. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the safety and efficacy of outpatient management of complicated acute appendicitis. For this purpose, a randomized clinical trial was designed. Selected patients who have undergone surgery for acute appendicitis are randomized into two groups. One group with hospitalization and another group without admission.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Hospitalization

Trials testing the same drug.

Other recruiting trials for Acute Appendicitis

Currently open trials in the same condition.

Other HJ23 trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06059365.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing